Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases

URN:NBN:SI:doc-U2NSRA4O2020Dodič-Fikfak, MetodaDolžan, VitaFranko, AlenkaGoričar, KatjaKovač, Viljemdocuments/doc/U/URN_NBN_SI_doc-U2NSRA4O_001.pdfdocuments/doc/U/URN_NBN_SI_doc-U2NSRA4O_001.txt154articlestr. 86-95, IX10.2478/raon-2020-00111318-209934748377URN:NBN:SI:doc-U2NSRA4OengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYazbestozadiagnostikaizpostavljenost azbestumaligni mezoteliommezotelinpeptidiEvaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases